Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

5:10 PM ET 8-K
M&A Deal John Hancock Comvest Private Income Fund

John Hancock Comvest Private Income Fund M&A Deal with Manulife Private Credit Fund

John Hancock Comvest Private Income Fund (JHCPIF) completed its acquisition of Manulife Private Credit Fund (MPCF) via a two-step merger process. In connection with the closing, the parties amended the merger agreement to allow for the issuance of fractional shares and streamlined the exchange process for book-entry shareholders.

Counterparty
Manulife Private Credit Fund
5:10 PM ET 8-K
Bankruptcy & Restructuring Petros Pharmaceuticals, Inc. PTPI

Petros Pharmaceuticals Bankruptcy & Restructuring

Petros Pharmaceuticals has entered into a General Assignment for the Benefit of Creditors (ABC) under California law, assigning all assets to PT Liquidation, LLC for liquidation. The company has ceased substantially all business operations and determined it can no longer continue as a going concern. Consequently, the entire Board of Directors and senior executive leadership, including the President and Chief Financial Officer, have resigned or been terminated.

Counterparty
PT Liquidation, LLC
5:05 PM ET 8-K
Capital Raise Inflection Point Acquisition Corp. Viii IPHX

Inflection Point Acquisition Corp. Viii Capital Raise

Inflection Point Acquisition Corp. VIII announced that holders of the units sold in its initial public offering may elect to separately trade the Class A ordinary shares and warrants starting October 5, 2026. The units were originally issued in an IPO of 28,750,000 units that closed on August 31, 2026. Following separation, the shares and warrants will trade on Nasdaq under the symbols 'IPHX' and 'IPHXW', respectively.

5:03 PM ET 8-K
M&A Deal Grindr Inc. GRND

Grindr Signs $250M M&A Deal with PurposeMed Inc.

Grindr Inc. has entered into a definitive agreement to acquire PurposeMed Inc., the parent company of telehealth provider Freddie, for $250 million in cash and stock plus up to $70 million in performance-based earnouts. The acquisition is intended to accelerate the 'Grindr Health' business by integrating HIV prevention and PrEP services directly into the Grindr app. The deal is expected to close in Q4 2026.

Value
$250M
Counterparty
PurposeMed Inc.
Earnings call
Sep 30, 2026, 5:15 PM ET

“Grindr has a direct line to millions of gay men, and Freddie brings the medical expertise to turn that reach into care. Together, we can revolutionize access to HIV prevention, just as Grindr revolutionized how gay men meet, and accelerate progress toward ending the HIV epidemic.”

George Arison, Grindr CEO and Chairman

“We built Freddie to make HIV prevention simple and accessible for everyone who needs it. Today we estimate Freddie prevents a new HIV transmission across the US and Canada every day. No one reaches the Freddie community like Grindr does.”

Dr. Husein Moloo, Co-founder and CEO of PurposeMed and Freddie
5:01 PM ET 8-K
M&A Deal Valaris Ltd VAL

Valaris M&A Deal with Transocean Ltd.

Valaris and Transocean received notification that the U.S. Department of Justice has closed its antitrust investigation under the HSR Act regarding their pending merger. The expiration of the HSR waiting period clears a major regulatory hurdle, with the companies now expecting the business combination to close in the fourth quarter of 2026.

Counterparty
Transocean Ltd.
4:59 PM ET 8-K
Capital Raise Beasley Broadcast Group Inc BBGI

Beasley Broadcast Group Capital Raise of $4.3M

Beasley Broadcast Group completed a registered direct offering and concurrent private placement with a single institutional investor, raising approximately $4.3 million in net proceeds. The offering consisted of 200,000 shares of Class A common stock and pre-funded warrants for 157,000 shares, priced at $14.00 per share/unit. The company intends to use the proceeds to reduce borrowings under its secured asset-based revolving credit facility.

Value
$4.3M
Counterparty
single institutional investor
4:54 PM ET 8-K/A
M&A Deal Spark I Acquisition Corp SPKLF

Spark I Acquisition M&A Deal with ZincFive, Inc.

Spark I Acquisition Corp provided a status update regarding its pending business combination with ZincFive, Inc., specifically announcing a one-time trust account contribution of $0.10 per share. This additional contribution is intended to increase the redemption price for shareholders and incentivizes them to withdraw existing redemption requests ahead of the extraordinary general meeting.

Counterparty
ZincFive, Inc.
4:49 PM ET 8-K
Capital Raise BioStem Technologies, Inc. BSEM

BioStem Technologies Capital Raise of $3M

BioStem Technologies entered into a securities purchase agreement with institutional investors for a $3.0 million private placement of 735,296 shares of common stock. The offering includes Series A and Series B warrants to purchase additional shares at an exercise price of $3.83 per share, which could provide an additional $5.6 million if fully exercised. Proceeds are intended for working capital and general corporate purposes.

Value
$3M
Counterparty
institutional investors
4:46 PM ET 8-K
Capital Raise Macquarie Energy Transition Infrastructure Fund, L.P.

Macquarie Energy Transition Infrastructure Fund Capital Raise of $683M

Macquarie Energy Transition Infrastructure Fund reported that its METI Program has raised approximately $683.3 million in aggregate cash consideration through September 1, 2026, as part of a continuous private offering. For the specific period of September 1, 2026, the Fund sold unregistered limited partnership units for approximately $2.74 million. The units were sold to accredited investors and qualified purchasers under Regulation D exemptions.

Value
$683M
4:43 PM ET 8-K
Capital Raise Macquarie Infrastructure Fund, L.P.

Macquarie Infrastructure Fund Capital Raise of $76.5M

Macquarie Infrastructure Fund, L.P. reported that its MIF Program issued interests for aggregate consideration of approximately $76.5 million on September 1, 2026, as part of its continuous private offering. Since October 31, 2025, the program has raised approximately $1,060.7 million in total cash consideration. The fund also disclosed a transactional net asset value (NAV) of $29.40 per Class I unit and $30.60 per Class E unit as of August 31, 2026.

Value
$76.5M
4:41 PM ET 8-K
Nasdaq/NYSE Compliance Notice Tevogen Inc. TVGN

Tevogen Nasdaq/NYSE Compliance Notice

Tevogen Inc. received written notice from Nasdaq confirming it has regained compliance with the $50 million minimum market value of listed securities requirement under Nasdaq Listing Rule 5450(b)(2)(A). This follows a previous notice regarding the market value of publicly held shares, and with both requirements now satisfied, all related Nasdaq compliance matters are closed.

Counterparty
The Nasdaq Stock Market LLC
4:36 PM ET 8-K
Product Launch Health In Tech, Inc. HIT

Health In Tech Product Launch

Health In Tech launched HitRix, an AI-powered platform designed to automate and streamline complex workflows in the $1 trillion U.S. self-funded health insurance market. The platform uses document intelligence to handle data ingestion and proposal comparison for brokers, leveraging the company's existing network of over 900 distribution partners.

4:33 PM ET 8-K
M&A Deal Ttm Technologies Inc TTMI

Ttm Technologies Signs $1.1B M&A Deal with EPIQ Design Solutions LLC

TTM Technologies completed the acquisition of Epiq Solutions, a provider of AI-enabled software-defined radios and RF products, for $1.1 billion in cash. The transaction was funded through a combination of $1.1 billion in new incremental senior secured term loans and proceeds from a previously completed senior notes offering. The acquisition is intended to bolster TTM's Aerospace & Defense portfolio and vertical integration strategy across land, air, sea, and space domains.

Value
$1.1B
Counterparty
EPIQ Design Solutions LLC
4:32 PM ET 8-K
Licensing Deal Take Two Interactive Software Inc TTWO

Take Two Interactive Software Licensing Deal with Microsoft Corporation

Take-Two Interactive Software entered into a new long-term XBOX Publisher License Agreement with Microsoft, effective September 17, 2026. The agreement grants Take-Two the rights to develop, publish, and distribute XBOX-compatible products across all Microsoft devices in exchange for wholesale payments and revenue sharing. This new agreement supersedes all previous publisher license agreements between the two companies.

Counterparty
Microsoft Corporation
Term
long-term
4:31 PM ET 8-K/A
M&A Deal Global Net Lease, Inc. GNL

Global Net Lease M&A Deal with Modiv Industrial, Inc.

Global Net Lease, Inc. filed an amended 8-K to provide updated pro forma financial information regarding its completed acquisition of Modiv Industrial, Inc. The amendment corrects clerical errors in the reporting period headings of the pro forma financial statements for the merger, which closed on August 12, 2026. The filing includes unaudited pro forma condensed combined balance sheets and statements of operations to reflect the impact of the Modiv merger on GNL's financial position.

Counterparty
Modiv Industrial, Inc.
4:31 PM ET 8-K
Capital Raise Antares Strategic Credit Fund

Antares Strategic Credit Fund Capital Raise of $6.1M

Antares Strategic Credit Fund raised approximately $6.1 million in September 2026 through the private placement of 242,434 common shares to unaffiliated investors. The company also declared a monthly distribution of $0.1852 per share and reported an aggregate net asset value (NAV) of approximately $2.1 billion as of August 31, 2026.

Value
$6.1M
Counterparty
unaffiliated investors
4:30 PM ET 8-K
Nasdaq/NYSE Compliance Notice Outlook Therapeutics, Inc. OTLK

Outlook Therapeutics Nasdaq/NYSE Compliance Notice

Outlook Therapeutics received a deficiency notice from Nasdaq on September 25, 2026, because its common stock failed to maintain a minimum bid price of $1.00 for 30 consecutive business days. The company has 180 calendar days, until March 24, 2027, to regain compliance by maintaining a closing bid price of at least $1.00 for ten consecutive business days. If compliance is not met, the company may be eligible for an additional 180-day period or face potential delisting.

Counterparty
The Nasdaq Stock Market LLC
Term
180 days
4:25 PM ET 8-K
Capital Raise Live Oak Acquisition Corp. VI LOVI

Live Oak Acquisition Corp. VI Capital Raise of $230M

Live Oak Acquisition Corp. VI completed its initial public offering (IPO) of 23,000,000 units at $10.00 per unit, raising $230 million in gross proceeds including the full exercise of the over-allotment option. Simultaneously, the company raised an additional $4.6 million through a private placement of warrants to its sponsor. The total proceeds of $230 million have been placed in a trust account as the SPAC seeks a target for a business combination.

Value
$230M
Counterparty
Live Oak Sponsor VI, LLC
4:22 PM ET 8-K
Nasdaq/NYSE Compliance Notice ESS Tech, Inc. GWHT

ESS Tech Nasdaq/NYSE Compliance Notice

ESS Tech, Inc. received notice from the NYSE that the exchange has determined to commence delisting proceedings for the company's common stock. The company failed to regain compliance with Section 802.01B, which requires at least $50 million in stockholders' equity or total market capitalization, within the maximum plan period. ESS Tech intends to appeal the determination to a Committee of the Board of Directors of the NYSE.

Counterparty
New York Stock Exchange
4:22 PM ET 8-K
M&A Deal Skydance Corp SKYD

Paramount Skydance M&A Deal with Warner Bros. Discovery, Inc.

Paramount Skydance Corporation and Warner Bros. Discovery (WBD) reached a consent decree with 12 U.S. states, resolving an antitrust lawsuit that sought to enjoin their pending merger. The U.S. District Court for the Northern District of California entered the decree and modified a no-close order, effectively clearing a major regulatory hurdle and permitting the merger to proceed subject to specific film release and theatrical window commitments.

Counterparty
Warner Bros. Discovery, Inc.
Term
5 years
4:16 PM ET 8-K
Licensing Deal Biomarin Pharmaceutical Inc BMRN

Biomarin Pharmaceutical Licensing Deal with Ascendis Pharma A/S

BioMarin entered into a definitive Settlement and License Agreement with Ascendis Pharma, granting Ascendis a non-exclusive worldwide license to certain patents for the commercialization of TransCon CNP (navepegritide). In exchange, BioMarin will receive royalties of 20% on net sales in the U.S. and 18% in the EU, Brazil, and South Korea through May 2030, while both parties agreed to dismiss all pending patent litigation.

Counterparty
Ascendis Pharma A/S
Term
through May 2030
4:15 PM ET 8-K/A
M&A Deal Bunker Hill Mining Corp. BHLL

Bunker Hill Mining M&A Deal with Silver47 Exploration Corp.

Bunker Hill Mining Corp. filed an amendment to its definitive arrangement agreement to acquire Silver47 Exploration Corp. The amendment corrects the exchange ratio to 0.1724 of a Bunker Hill share for each Silver47 share and clarifies that termination and expense reimbursement fees are denominated in Canadian dollars.

Counterparty
Silver47 Exploration Corp.
4:13 PM ET 8-K
Capital Raise Vroom, Inc. VRM

Vroom Capital Raise of $20M

Vroom's subsidiary, Vroom Automotive, LLC, issued 16,000 Series A1 and 4,000 Series B1 preferred units to SPE Holdings 2026-1 for $20 million in gross proceeds. The proceeds are intended to repay existing obligations and purchase residual interests in asset-backed securitization trusts. The preferred units carry quarterly distribution rates tied to SOFR plus a spread of 8.50% to 9.25%.

Value
$20M
Counterparty
SPE Holdings 2026-1
4:10 PM ET 8-K
Divestiture Inogen Inc INGN

Inogen Divestiture to Rotech Healthcare Inc. for $24.8M

Inogen agreed to sell substantially all assets of its U.S. oxygen rental business to Rotech Healthcare for an estimated $24.8 million. The divestiture is intended to streamline Inogen's commercial model and shift focus toward its product supply business, supported by a new long-term supply agreement with Rotech. Upon closing, Inogen will also increase its share repurchase authorization from $30 million to $45 million.

Value
$24.8M
Counterparty
Rotech Healthcare Inc.
4:10 PM ET 8-K
Contract Win Guidewire Software, Inc. GWRE

Guidewire Software Wins Contract from A top 10 US-based insurance carrier

Guidewire Software entered into a multi-year agreement with a top 10 US-based insurance carrier to migrate their personal lines book of business to Guidewire Cloud and PolicyCenter. The deal makes this customer one of Guidewire's top 10 clients as measured by fully ramped annual recurring revenue.

Counterparty
A top 10 US-based insurance carrier
Term
multi-year
4:06 PM ET 8-K
Contract Win Rank One Computing Corp ROC

Rank One Computing Wins $64.3M Contract from U.S. Department of Justice Executive Office for United...

Rank One Computing (ROC) was awarded a $64.3 million contract by the DOJ to develop and support a Digital Evidence Review Platform (DERP) for federal prosecutions. The agreement includes a one-year base period worth $7.4 million followed by seven one-year option periods. This contract validates ROC's expanded digital evidence platform following its acquisition of ZTC and establishes a strategic beachhead in the federal market.

Value
$64.3M
Counterparty
U.S. Department of Justice (DOJ) Executive Office for United States Attorneys (EOUSA)
Term
8 years
4:05 PM ET 8-K
Capital Raise AGL Private Credit Income Fund

AGL Private Credit Income Fund Capital Raise of $70M

AGL Private Credit Income Fund closed the sale of approximately 2.99 million common shares for $70 million in gross proceeds. The capital was raised through a drawdown notice issued to existing shareholders under subscription agreements to fund the fund's investment activities.

Value
$70M
4:05 PM ET 8-K
Capital Raise FrontView REIT, Inc. FVR

FrontView REIT Capital Raise of $20M

FrontView REIT, Inc. issued 200,000 shares of Series A Convertible Preferred Stock at $100.00 per share, generating gross proceeds of approximately $20.0 million. The issuance was made to a group of private investors including Maewyn FVR II LP and Petrus Special Opportunities Fund under a previously established investment agreement.

Value
$20M
Counterparty
Maewyn FVR II LP, Rebound Investment, LP and Petrus Special Opportunities Fund, L.P.
4:05 PM ET 8-K
Capital Raise Lantern Pharma Inc. LTRN

Lantern Pharma Capital Raise of $4M

Lantern Pharma Inc. entered into a securities purchase agreement for a registered direct offering of 1,469,725 common shares and 2,200,000 pre-funded warrants at $1.09 per share. The offering raised approximately $4 million in gross proceeds, with a concurrent private placement of warrants that could provide an additional $4 million if fully exercised. The company intends to use the proceeds for working capital and general corporate purposes.

Value
$4M
Counterparty
institutional investor
4:05 PM ET 8-K
Capital Raise Cimg Inc. CIMG

Cimg Capital Raise of $8.7M

CIMG Inc. entered into a securities purchase agreement to issue and sell 3 billion shares of common stock to non-U.S. investors in a private placement. The company expects to raise $8.7 million in gross proceeds, with investors permitted to pay in either U.S. dollars or Bitcoin.

Value
$8.7M
Counterparty
Certain non-U.S. investors

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.